Clinical trial
A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease
NCT02912936
Study timeline
Study start (actual)2016-09-01Date precision: month
Registry last updated2026-04-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer's Diseaseunresolved
Primary Progressive Non-fluent Aphasiaunresolved
Frontotemporal Dementia (FTD)unresolved
Interventions
Ketogenic medium chain triglyceride drink (MCT drink)DIETARY_SUPPLEMENT
PlaceboDIETARY_SUPPLEMENT
Sponsors & collaborators
University of British Columbialead sponsor
Université de Sherbrookecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02912936 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.